Clinical Trials

Showing 221 - 240 of 492 trials
Title Investigatorsort icon Disease(s)
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission after Non-Myeloablative Therapy in Patients with High-Risk Neuroblastoma
[Protocol 09-159]
Kushner, Brian
  • Neuroblastoma
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma
[Protocol 09-160]
Kushner, Brian
  • Neuroblastoma
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in the Bone Marrow
[Protocol 09-161]
Kushner, Brian
  • Neuroblastoma
A Study Offering Treatment with 3F8 and GM-CSF in Patients with High-Risk Neuroblastoma
Relapsed/Refractory
[Protocol 13-260]
Kushner, Brian
  • Neuroblastoma
A Phase I Study of the Hu3F8 Antibody plus GM-CSF in Patients with Relapsed/Refractory Neuroblastoma
Relapsed/Refractory
[Protocol 12-230]
Kushner, Brian
  • Neuroblastoma
A Phase III Study of Dapsone Gel versus Moisturizer (Placebo) to Treat Cetuximab-Related Rash
[Protocol 13-012]
Lacouture, Mario
  • Colorectal Cancer
  • Head & Neck Cancer
A Phase I Study of Topical Calcitriol (Compound 31543) to Prevent Hair Loss in Women Receiving Paclitaxel for Advanced Breast Cancer
[Protocol 11-205]
Lacouture, Mario
  • Breast Cancer
An Observational Study of Treatment Patterns and Outcomes in Patients with Advanced Basal Cell Carcinoma or Basal Cell Carcinoma Nevus Syndrome
[Protocol 13-221]
Lacouture, Mario
  • Basal Cell Carcinoma
A Phase III Study of Hormone Therapy with and without Chemotherapy in Patients with HER2-Negative Breast Cancer and 1-3 Positive Lymph Nodes and a Recurrence Score of 25 or Less
[Protocol 12-118]
Lake, Diana
  • Breast Cancer
A Study Comparing Different Stem Cell Mobilization Approaches in Patients with Multiple Myeloma
[Protocol 13-176]
Landau, Heather
  • Hematology
    • Multiple Myeloma
A Phase I/IIA Study of Carfilzomib plus High-Dose Melphalan Before Autologous Stem Cell Transplant in Patients with Multiple Myeloma
[Protocol 12-144]
Landau, Heather
  • Hematology
    • Multiple Myeloma
A Phase III Study of Dexamethasone plus MLN9708 or Standard Therapy in Patients with Recurrent or Persistent Systemic Light Chain Amyloidosis
[Protocol 13-088]
Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase I Study of Carfilzomib in Patients with Previously Treated Systemic Light Chain Amyloidosis
[Protocol 12-276]
Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase II Study of Bendamustine and Dexamethasone in Patients with Relapsed Amyloidosis
[Protocol 12-257]
Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase I Study of NEOD001 in Patients with Light Chain Amyloidosis
[Protocol 12-280]
Landau, Heather
  • Hematology
    • Hematologic Disorders
    • Hematologic Malignancies
A Phase II Study of Capecitabine with Lapatinib or Neratinib in Patients with Metastatic HER2-Positive Breast Cancer
[Protocol 13-121]
Latif, Asma
  • Breast Cancer
Quality of Life Assessment in Breast Cancer Patients with Radiation-Induced Telangiectasias Treated with Pulsed Dye Laser
[Protocol 13-013]
Lee, Erica
  • Breast Cancer
  • Quality of Life
  • Survivorship
A Study of Customized Treatment for Nasopharyngeal Cancer Based on Epstein-Barr Virus DNA
Newly Diagnosed
[Protocol 14-162]
Lee, Nancy
  • Head & Neck Cancer
A Phase II Study of Intensity-Modulated Radiation Therapy for the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer
[Protocol 13-070]
Lee, Nancy
  • Head & Neck Cancer
  • Thyroid Cancer
Feasibility Study Using Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Head and Neck Cancer Patients
[Protocol 04-070]
Lee, Nancy
  • Head & Neck Cancer